[Suppression of immunoglobulin synthesis in myeloma MORS 21 cells by an alkylating oligonucleotide derivative complementary to the mRNA coding for light-chain immunoglobulin].
D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D002478:Cells, Cultured; D003864:Depression, Chemical; D005815:Genetic Code / Q000187:drug effects*; D007147:Immunoglobulin Light Chains / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D009841:Oligonucleotides / Q000494:pharmacology*; D010954:Plasmacytoma / Q000276:immunology*; D012333:RNA, Messenger / Q000235:genetics*; D012334:RNA, Neoplasm / Q000235:genetics*
D000477:Alkylating Agents; D007147:Immunoglobulin Light Chains; D009841:Oligonucleotides; D012333:RNA, Messenger; D012334:RNA, Neoplasm
Podavlenie sinteza immunoglobulina v kletkakh mielomy MORS 21 alkiliruiushchim proizvodnym oligonukleopeptida, komplentarnogo mRNK, kodiruiushcheĭ legkuiu tsep' immunoglobulina.